What it is and what it's history?

 

Donato Perez Garcia,MD (1896-1971) and Carlos Sosa the first patient successfully treated with IPT. El Universal Newspaper, February of 1934.

IPTLD Targeted low dose chemo using insulin is a treatment that uses a reduced dose of chemotherapy drugs thus having few side effects. In the majority of patients it is a kinder, gentle form of treatment for cancer.
IPTLD ® has been in existence as a therapy since 1930, and has been used successfully as a treatment for cancer since 1946.  Insulin Potentiation Therapy was initially developed in 1930 for the treatment of human disease by my grand father, Donato Perez Garcia, Sr. MD (1896-1971). A surgeon lieutenant in the Mexican military establishment, his preliminary work with insulin involved an innovative course of self-treatment for a gastrointestinal problem that he suffered from for years. All previous treatments had failed to resolve it. 
When he first learned of the then newly discovered hormone insulin being used to treat diabetes, he noted that, in addition to diabetes, its use was also indicated for the treatment of non-diabetic malnutrition. So he decided to try it on himself. The treatment was completely successful; his symptoms disappeared and his weight became normal.
Reflecting on his own experience, Dr. Perez Garcia did what many innovators in the medical field do: he asked himself "why?”. He considered that the insulin might have helped his body tissues assimilate the food he had eaten and wondered if perhaps insulin might help tissues assimilate medications.  Over the years he worked to investigate its use on many other diseases, eventually developing the therapy to treat cancer. He was followed by his son, Donato Perez Garcia Bellon, MD and his grandson, Donato Perez Garcia, MD.